top of page

Our Investment Research Lab


KOSPI Up 85%. NIKKEI Up 22%. Nifty 50 Down 3%. What’s Really Driving Asia’s Market Divergence?
Asia’s recent market divergence is being explained as an AI story. But the bigger shift may be institutional. The next phase of NIFTY outperformance may depend less on AI narratives and more on whether India can build the financial infrastructure


Is India’s Current Account Deficit Actually a Capital Markets Problem?
India’s biggest economic bottleneck is not AI, manufacturing, infrastructure, or entrepreneurship. It is capital markets. India does not have a shortage of growth opportunities. It has a shortage of scalable and frictionless pathways for global capital to enter, compound, and exit predictably. That distinction matters enormously. The investment opportunities available in India today far exceed the capital available domestically. Every serious ambition India has, AI, manufactu
AltG
May 11


A 10x decade for Eternal?
Deepinder & team built the best food business in the world. What's next? Eternal Limited — the company formerly known as Zomato — reported its Q4FY26 results on Tuesday. The numbers are the news. What sits behind them is the story. In 2008, Deepinder Goyal was riding a motorbike around Delhi, collecting paper menus from restaurants, scanning them, and uploading them to a website that drew about 5,000 visitors a day. He was not, by his own account, building a business. Eightee
AltG
Apr 28


Inside Sun's $12bn Organon Deal: The Math, the Comps, and the Verdict
At ~11x trailing EBITDA, Sun's $13bn bid for Organon sits at the bottom of the India pharma comp set — half of what Mankind paid for Bharat Serums and well below Torrent-JBCP at 25x. The headline multiple looks cheap. It isn't. Organon comes with $8.6bn of MSD-inherited debt, a shrinking revenue base, and an integration challenge that financial sponsors can't price. This is a strategic buyer's deal at a strategic buyer's multiple — and Sun is the only bidder equipped to actua
AltG
Apr 25


Why One Basis Point Matters More Than The US India Trade Deal
A single basis point shift in global index weights can unlock as much capital for India as a major trade deal. As the US–India agreement takes shape, the real growth lever lies in capital-market reform, not tariffs or quotas.
AltG
Feb 4


India’s Economic Survey Is Right on AI — and Still Gets It Wrong
The Economic Survey correctly frames AI as infrastructure, but it misses the true regime change. AI isn’t just a productivity tool; it’s a tool for collapsing uncertainty. India’s growth has long been throttled by volatility and high capital costs. By shifting from manual information processing to systematic decision processing, AI stabilizes cash flows and makes Indian MSMEs legible to global lenders. This is the most powerful growth unlock since liberalization.


Davos Is Looking at AI Backwards And Misunderstanding AI’s Most Important Market - India
Davos views AI through the lens of efficiency, but in India, the challenge isn't optimization—it’s variance. With 65 million MSMEs, the hurdle to credit isn't a lack of profit, but unstable cash flows. AI’s true role here is resolution over automation. By collapsing variance and making small businesses "legible" to lenders, AI unlocks capital at scale. The result isn't a tech boom, but a fundamental repricing of the Indian economy.


India’s Power Grid Is Due for a Redesign — Not Just an Upgrade
India’s power challenge is no longer about adding generation capacity. It is about managing volatility. Like pharma once redesigned its supply chain to distribute risk, the power grid must shift from asset-heavy planning to system-level orchestration.
AltG
Jan 5


Why Is the Rupee Falling When Growth Is Strong — Is the Capital Account to Blame?
Capital account reform is the real opportunity hiding behind the USD/INR move — not to defend the currency, but to turn it into a structural advantage for India’s next decade.
AltG Investment Research Lab
Dec 17, 2025


Distressed Investing In India: The Rise of a New Investment Class
Distressed Investing In India: The Rise of a New Investment Class
AltG Investment Research Lab
Sep 18, 2024


Blackstone Cipla Deal or Torrent Cipla Deal: The Clash Of Private Equity And Pharma Giants
By AltG Innovation Centre On Behalf Of Poornima Vardhan And Taponeel Mukherjee Cipla Deal has taken the spotlight in recent weeks with a...
By AltG Innovation Centre
Oct 9, 2023


The Agilus Diagnostics IPO: What You Should Be Looking For In The 2nd Largest Indian Diagnostics?
By AltG Innovation Centre On Behalf Of Poornima Vardhan And Taponeel Mukherjee The 2nd largest Diagnostic service provider, Agilus...
By AltG Innovation Centre
Oct 2, 2023
bottom of page

